The New York Times has highlighted the importance of frequency based neuromodulation derived from EEG. Use of EEG to generate personalized brain stimulation protocols is covered by Wave Neuro patents.

Wave Neuro announced today that it has acquired the assets of NeoSync, Inc. NeoSync is a pioneer in personalized, low-energy brain stimulation for the treatment of Major Depressive Disorder and other diseases of the Central Nervous System (CNS).